The overexpression of FRα was shown in cervical and brain tumors, whereas FRβ was detected in acute and chronic myelogenous leukemia (AML and CML) [65–67] and in tumor-associated macrophages of various cancers [68–70]. Here, FOLR2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.